From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Phorm – Avoid like the plague

By Lucian Miers | Thursday 6 March 2014


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I had a look at Phorm (PHRM) the other day, a trip down memory lane as I last followed it in 2008 when it rose to and collapsed from £35 a share.   This was during a very brief period of fame and notoriety when the company was attempting to persuade UK ISPs, BT being the most prominent, to adopt its controversial and invasive internet advertising technology.  No UK ISPs did end up going with Phorm in the end owing to the questionable legality of its practices and the unwelcome publicity that it attracted.  Hence the collapse. 



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 22:12:24